Fact CheckerSign in

NCT06187064Completed

Combination Primary Care and Prevention Services for Women Who Inject Drugs and Exchange Sex in Seattle, Washington

Source: ClinicalTrials.gov · Last updated 20 Feb 2026

Brief summary (registry, in English)

The investigators will implement a non-randomized observational clinical trial that will include a pop-up clinic for women who inject drugs (WWID) near venues for exchange sex and drug use in north Seattle. The pop-up clinic will be housed within a van and serve as a research extension of the SHE Clinic, a Harborview Medical Center run clinic for women who exchange sex and use drugs in north Seattle. Through the implementation of the pop-up clinic, the investigators will aim to assess: 1. The impact of the pop-up clinic on uptake and sustained use of HIV pre-exposure prophylaxis (PrEP) and medications for opioid use disorder (MOUD) among WWID. 2. The impact of point of care (POC) sexually transmitted infection (STI) testing on STI treatment completion rates. 3. The acceptability and feasibility of providing HIV prevention care for WWID and exchange sex in a pop-up van clinic.

Status (registry)
Completed
Study type
Interventional
Enrollment
50 (actual)
First submitted
5 Dec 2023
Start date
18 Mar 2024
Primary completion date
12 Mar 2025
Lead sponsor
University of Washington
Diseases
HIV
NCT number
NCT06187064

What you commit to

  • Study type: Interventional
  • Participants enrolled: 50
  • From 18 Mar 2024 to the primary completion date, 12 Mar 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Never injected drugs

Other illness

  • Living with HIV

Age

  • \<18 years of age

Other

  • Medical or psychological co-morbidities that prevent participation per study team assessment.
  • Non-English speaking

Who the study is looking for

  • ≥18 years of age
  • Female identifying
  • Ever injected drugs
  • Not known to have HIV
  • Willing and able to provide informed consent to participate in the study

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Harborview Medical Center
Coordinator of this site? Confirm its status
SeattleUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.